COLD-CHAIN BIOPOTENT
Live / Applied — Ex parte appeal pending (as of 14 Apr 2026)
What this means for you
Not registered yet, but its 26 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97567159
- Mark type
- Word mark
- Filed
- 26 Aug 2022
- Published for opposition
- 30 Jul 2024
- Attorney of record
- KAREN A. WEBB
Goods and services
- Class 005 — Pharmaceuticals: Nutritional supplement in the nature of superfood powder; Food supplements for humans; nutritional supplements in the nature of a nutrient dense, protein based drink mix; dietary and nutritional supplements, namely, colostrum powders sold as a component ingredient of dietary and nutritional supplements; dietary supplements for humans; functional foods, namely, a natural food ingredient sold as a component ingredient of dietary and nutritional supplements
- Class 029 — Meats and processed foods: Milk products excluding ice cream, ice milk and frozen yogurt; smart food, namely, colostrum
Owner
- Rahal Biosciences, Inc., Bonita Springs, FL, US
- Rahal Biosciences, Inc., Brooklyn, NY, US
Board proceedings on this mark
- Ex Parte Appeal No. 97567159 — Rahal Biosciences, Inc., filed 14 Apr 2026 (Pending Reconsideration)
Prosecution history
- 14 Apr 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 14 Apr 2026 — EX PARTE APPEAL-INSTITUTED
- 14 Apr 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 14 Apr 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 13 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 Oct 2025 — FINAL REFUSAL E-MAILED
- 14 Oct 2025 — SU - FINAL REFUSAL - WRITTEN
- 15 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jul 2025 — NON-FINAL ACTION E-MAILED
- 21 Jul 2025 — SU - NON-FINAL ACTION - WRITTEN